Market Research Blog

The global Portable Ultrasound Bladder Scanner Market was valued at US$ 126.3 Mn in 2021 and is expected to reach US$ 191.7 Mn by 2028. As per the findings of a new Future Market Insights (FMI) report, the global portable ultrasound bladder scanner market will thrive on the back of rising adoption of non-invasive diagnostic procedures in urology imaging.

Advancements in ultrasound bladder scanner reduce the chance of catheter-associated urinary tract infection (CAUTI), reduce the time for operating procedures with no sonographer required, thus driving the growth of the portable ultrasound bladder scanner market during the forecast period. Distribution channels are well established for portable ultrasound bladder scanner due to increase in demand from end users such as hospitals, diagnostic centers, clinics and ambulatory surgical enters.

The key players in portable ultrasound bladder scanner market are C. R. Bard, Inc., Verathon Inc., SRS MEDICAL SYSTEMS INC, Laborie Medical Technologies Inc., Echo Son SA, Signostics Inc., dBMEDx Inc., Sonostar Technologies Co., Limited, Caresono Technology Co., Ltd, and GE Healthcare Inc.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2008

Key Takeaways – Portable Ultrasound Bladder Scanner Market Study

• The market share of 3D portable ultrasound bladder scanner devices is evaluated to grow at a significant rate by the end of 2028, as it provides high-end accuracy for measuring bladder volumes during urodynamics, thus surpassing the market of 2D portable ultrasound bladder scanner.
• Sales of portable ultrasound bladder scanner are envisaged to be higher in the region of North America. The rising prevalence of urological diseases among women and increasing adoption of portable ultrasound bladder scanner for diagnosis application are few factors contributing to the growth of the portable ultrasound bladder scanner market in the region.
• Portable US bladder scanners can be moved and carried to any location as and when required, due to its compact structure. One of the primary factors driving the portable bladder ultrasound scanner market is the accuracy and easy to use in both adults and children.

Technological advancements and well-established distribution network will accelerate the growth of portable ultrasound bladder scanner market in the following years. Furthermore, deeper penetration of internet and rapid E-commerce expansion will significantly support the growth of portable ultrasound bladder scanner sales.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-2008

Portable Ultrasound Bladder Scanners Replacing Unnecessary Catheterization

Portable ultrasound bladder scanner has reduced the need for unnecessary catheterization, which also helps in the prevention of patients’ dignity and discomfort. Patients suffering from urological disorders opt for cardio portable ultrasound bladder scanner due to its less complex nature as compared to other diagnostic solutions. It also reduces the risk of catheter-associated urinary tract infection.

Such promising attributes facilitates the use of advanced portable ultrasound bladder scanners in hospitals, clinics, ambulatory surgical centers and others. Thus, enhanced patient care and addressing clinical challenges worldwide are expected to enhance demand for portable ultrasound bladder scanner during the forecast period.

Seeking More Information About Report Inclusions?

The portable ultrasound bladder scanner market, a new study from Future Market Insights, opines on the evolution of the portable ultrasound bladder scanner market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of product type (3D portable ultrasound bladder scanner, and 2D portable ultrasound bladder scanner), and end user (hospitals, diagnostic centers, clinics, and ambulatory surgical centers) in seven prominent regions.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The Saudi Arabia pharmaceutical market is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026). The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, the Saudi Arabia pharmaceutical market is anticipated to procure value worth US$ 5,209.5 Mn at a y-o-y growth of 6.0 % over 2015. The mounting demand for branded drug products will continue to incite the growth of the Saudi Arabian pharmaceutical market in 2016.

The demand for pharmaceuticals in Saudi Arabia is expected to register substantial growth owing to the increasing penetration of health insurance companies and the rising incidence rate of non-communicable diseases. Furthermore, the exceptional rise in the per capita income of Saudi Arabia is also expected to foster the demand for branded pharmaceutical drugs. Another key factor driving the growth of the pharmaceutical market in Saudi Arabia is the country’s strategic move to allow 100% FDI in the pharmaceuticals sector. Although, the shortage of profound indigenous research capacity in the pharmaceutical industry and the delayed registration of drug and medicine patents is expected to limit the expansion of the market in 2016 and beyond.

Based on the product type, the pharmaceutical market in Saudi Arabia is expected to witness an upsurge in the prescription-type branded drug products. In terms of market value, the branded drugs are estimated to reach US$ 2,760.8 Mn by 2016-end. The demand for generic drugs is projected to secure steady growth, attributing to the insisting promotion of generic drug adoption by healthcare insurance providers.

On the basis of the diseases, the pharmaceutical drugs used for treatment of cardiovascular diseases will continue exhibiting robust growth in 2016. The demand for cardiovascular medications will continue to surge due to the prominence of circulatory disorders in Saudi Arabia. Additionally, the rising prevalence of disorders related to body sugar levels is expected to make diabetes a rapidly growing disease-based sub-segment in the Saudi Arabia pharmaceutical market.

The pharmaceutical market in Saudi Arabia is also segmented on the basis of distribution channel, where retail pharmacies will continue to account for 80% market share compared to hospital pharmacies. The westernised modernisation of retail pharmacies in Saudi Arabia has led to the availability of a wide range drugs and medicinal products, thereby attaining a considerable growth in the retail pharmacy sub-segment in 2016 and further.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gc-1733

The rising resource potential in Saudi Arabia is projected to positively reform the production environment for pharmaceutical manufacturers. In order to expand the market’s size, structuring alliances with well-established native companies is predicted to be a key strategy for global pharmaceutical leaders. The key players in the Saudi Arabia pharmaceutical market include Novartis AG, SPIMACO, Pfizer Inc., and Glaxosmithkline plc., Jamjoom Pharma,  and Tabuk Pharmaceutical Manufacturing Co. among others.

Long-term Outlook: The Saudi Arabia pharmaceutical market is expected to expand at a CAGR of 9.0% over the forecast period 2016-2026. In terms of market value, the pharmaceutical market in Saudi Arabia is estimated to be worth US$ 12,281.4 Mn by the end of forecast period.

Key Segments Covered

Product Type:

• Prescription Products
  • Branded Drugs
  • Generic Drugs
• Over The Counter (OTC) Products

Disease Type:

• Cardiovascular Diseases
• Diabetes
• Cancer
• Obesity
• Infectious Diseases
• Other Diseases

Distribution Channel:

•  Hospital Pharmacies
• Retail Pharmacies

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gc-1733

Table of Content

1. Research Methodology
2. Assumptions & Acronyms
3. Executive Summary
4. Saudi Arabia Pharmaceutical Market Overview

4.1. Definition

4.2. GCC Pharmaceutical Market Overview

4.3. Value Chain Analysis

4.4. Trade Associations and Trade Fairs

4.5. PESTLE Analysis

4.6. Saudi Arabia Pharmaceuticals Market Overview, 2015–2026

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gc-1733

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

In a recent market survey, ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts an impressive growth outlook for the platelet-rich plasma (PRP) market share. The market valuation reached US$ 370.78 Mn in 2021 and is poised to expand at a 6% CAGR through 2031.

Growth registered in the platelet-rich plasma market is attributable to increasing applications of PRPs in various procedures such as cosmetic, orthopedic, neurological, and maxillofacial treatments. Increasing awareness regarding the advantages of platelet-rich plasma in wound healing and tissue regeneration will further propel sales in the market.

PRP is being widely used in cosmetic surgeries aimed at improving facial structure and aesthetics, such as skin texture, and color. In addition, PRP is gaining wide acceptance as a key ingredient used in microneedling, botox treatments, acne scar removal, and laser treatments, which is spurring demand in the market.

Besides this, usage of PRPs in orthopedic treatments is fostering market sales, owing to its cost-effectiveness and negligible side effects. PRPs are increasingly finding application in joint pain treatment, cartilage reconstruction, fracture treatments, and other arthritic treatments.

With rising incidence of cosmetic procedures and sports-related injuries in countries including the U.S, the U.K., and Germany, the market is anticipated to garner significant revenue over the forecast period.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1722

Intensive research and development, coupled with the prevalence of leading market players will further augment platelet-rich plasma market growth, with expansion at 12.4% by volume.

Additionally, growing investments in healthcare infrastructure and increasing disposable income will provide tailwinds to platelet-rich plasma sales in counties such as India, China, Brazil, and South Korea, shaping the demand outlook positively.

“Growing use of platelet-rich plasma in chronic wound healing, cosmetology, and orthopedic procedures, along with product innovations by leading market players will augment market growth in the upcoming years,” says an FMI analyst.

Competitive Landscape

Harvest Technologies Corp., Zimmer Biomet Holdings Inc., Arthrex, Inc., Arteriocyte Medical Systems, Inc., Dr. PRP America, Cesca Therapeutics, Inc., and Regen Lab SA are among the prominent players operating in the global platelet-rich plasma market. As per FMI’s analysis, tier-1 players will account for 15-20% of the total market share.

Growth strategies leveraged by top manufacturers of platelet-rich plasma include strategic partnerships, mergers, acquisitions, and collaborations to launch innovative PRP treatment methods in the market. For instance:

• In July 2021, Arthrex Inc. announced an exclusive partnership with Celularity Inc., a USA-based biotechnology company to distribute and commercialize Celularity Inc.’s biomaterial products for orthopedic procedures and sports medicine.
• In September 2019, Cesca Therapeutics Inc., a global leader in autologous cell therapies for regenerative medicine, and ThermoGenesis, Cesca’s wholly owned device subsidiary, announced a global distribution agreement in which the company will supply its X-series cell processing products to major life science distributors to expand its global footprint.

 

Get In Touch With Our Team For 20% Flat Discount :

https://www.futuremarketinsights.com/ask-question/rep-gb-1722

Key Takeaways from Platelet Rich Plasma Market Survey

• Based on product type, pure platelet-rich plasma (P-PRP) will dominate the segment, due to advanced wound healing properties and cost-effectiveness.
• Autologous platelet-rich plasma will account for maximum sales in the origin segment, with high applications in treatment of nonhealing ulcers.
• In terms of application, cosmetic procedures, surgical and non-surgical, will dominate the segment.
• The U.S. is projected to lead sales of platelet-rich plasma due to increasing incidence of cosmetic surgeries in the country.
• The U.K. will provide lucrative growth opportunities for leading players with intensive research and development in the country aimed at PRP product innovation.
• Germany will emerge as a profitable market for global and regional players, owing to an influx of patients seeking PRP-based treatments in the country.
• Increasing investments in healthcare infrastructure in India, along with growing awareness regarding advantages of PRP will augment market growth.
• Japan and South Korea will account for 5% of the total market share.

More Insights on the Platelet Rich Plasma Market

In its latest report, FMI offers an unbiased analysis of the global platelet-rich plasma market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (pure platelet-rich plasma, leukocyte platelet-rich plasma, leukocyte platelet-rich fibrin), origin type (autologous, homologous, and allogenic), application type (orthopedic surgery, cosmetic surgery, general surgery, neurosurgery and other surgeries including urological, cardiothoracic, periodontal, oral and maxillofacial), and across seven regions (North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa).

Platelet Rich Plasma Market by Category By Product Type:

• Pure-Platelet Rich Plasma (P-PRP)
• Leukocyte-Platelet Rich Plasma (L-PRP)
• Leukocyte-Platelet Rich Fibrin (L-PRF)

By Origin Type:

• Autologous
• Homologous
• Allogenic

By Application Type:

• Orthopedic Surgery
• Cosmetic Surgery
• General Surgery
• Neurosurgery
• Other Surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1722

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the global protein A resins market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 536.6 Mn in 2020 to over US$ 1.2 Bn by 2031. This reflects a cumulative CAGR of around 8.1% over the forecast period (2021-2031).

Increasing researches conducted on monoclonal antibodies are driving demand for protein A resin. Since the commercialization of the first therapeutic monoclonal antibody in 1986, till May 2021, around 100 monoclonal antibody products have been approved by the U.S. FDA and European Medical Agency for the treatment of various diseases such as cancer.

Monoclonal antibody therapy for the treatment of mild to moderate COVID-19 in patients has also been approved by the FDA under Emergency Use Authorization (EUA).

Studies on monoclonal antibodies have indicated that more monoclonal antibody therapies are in the process of getting FDA approval and can be marketed in the near future to cater to rising demand in the global life sciences industry. Thus, increasing research on monoclonal antibodies (mAb) is expected to fuel the demand and utilization of protein A resin for purification and precipitation purposes.

For the purification of monoclonal antibodies (mAb), different technologies are available which includes membrane chromatography, mixed chromatography, and aqueous two-phase extractions (ATPS). However, protein A resin holds the top position for the purification of mAbs.

With many industries facing issues of leaching of ligand and resistance during the commercialization of monoclonal antibodies (mAbs), the availability of next-generation protein A resins with improved purification conditions, such as alkaline-stability, and with very low ligand leaching, is expected to increase the production and throughput demand for protein therapeutic processes.

Furthermore, in June 2018, Purolite Life Sciences launched a novel next-generation Protein A agarose resin, Praesto Jetted A50. GE Healthcare, in 2017, introduced a next-generation protein A resin, MabSelect PrismaA, which was designed to enable biopharma manufacturers to improve their mAb purification capacity by up to 40% over GE Healthcare’s existing protein A affinity medium. These product launches are expected give tailwinds to growth registered in the market.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1720

Key Takeaways from Protein A Resin Study

• By product, the natural protein A resin hold the maximum share of 62.8% in 2021. Natural protein A is derived from a bacterial cell of the staphylococcus aureus species and mainly used in the purification of monoclonal antibodies.
• By matrix, the agarose based matrix of protein A resin account for 85.8% of the market share in 2021 indicating the highest demand, offering high binding specificity when in comparison to other matrices and are widely used for the attachment of ligands that bind proteins.
• By application, the antibody purification of protein A resin segment will account for 74.8% of the market share in 2021.
• By end user, the biopharmaceutical manufacturers will account for 79.2% of the market share in 2021.
• By region, North America held the largest share of 35.7% of the global protein A resins market in 2021.
• The U.S. will emerge as a leading market in North America, while growth registered in Europe will be spearheaded by Germany and the U.K.

“Increasing demand of protein A Resins for biologics production including monoclonal antibody and biosimilars is expected to drive the demand of protein a resin over the decade. To capitalize on existing opportunities, market players are expected to push investment towards product launches and research initiatives,” says the FMI Analyst

Who is Winning?Some of the leading manufacturers of protein A resin market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

• In August 2021, Danaher Corporation acquired Aldevron and stated that Aldevron will work as a stand-alone operating firm and brand within the life sciences segment of Danaher to provide a vast range of custom biologic services, including plasmid DNA production, mRNA production, and antibody development.
• On 11 February 2021, Thermo Fisher Scientific Inc. started the online offering of its essential Thermo Scientific Dionex Easion and Thermo Scientific Dionex Aquion Ion Chromatography (IC) systems through easy online ordering.  This step was undertaken in order to reduce the in-person transaction during the pandemic.
• In October 2020, Kaneka Corporation collaborated with the biomedical research institute “de Duve Institute” of the University of Louvain, wherein they signed a research collaboration agreement in order to develop innovative biomedicine production technologies and strengthen and expand the company’s current biomedicine CDMO business.
• In April 2020, Bio-Rad Laboratories, Inc. launched a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19.

The key market players covered by FMI include :

• GE Healthcare
• Thermo Fisher Scientific
• Kaneka Corporation
• JNC Corporation
• Purolite Life Sciences
• Bio-Rad Laboratories Inc.
• JSR Corporation (JSR Life Sciences LLC)
• Repligen
• Tosoh Bioscience
• Merck Group (Merck Millipore)
• Novasep Holdings SAS
• Agilent Technologies Inc.
• GenScript
• Abcam PLC (Expedeon Ltd.)
• Avantor Inc.
• Takara Bio
• PerkinElmer Inc.
• Suzhou Nanomicro Technology Co. Ltd.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1720

Key Segments:

Product:

• Natural Protein A Resin
• Recombinant Protein A Resin

Matrix:

• Agarose Based Matrix
• Glass or Silica Based Matrix
• Organic Polymer Based Matrix

Application:

• Immunoprecipitation
• Antibody Purification

End User:

• Biopharmaceutical Manufacturers
• Clinical Research Laboratories
• Academic Institutes

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The Neurovascular Devices / Interventional Neurology Market is projected to increase between 2022 and 2032 at a CAGR of 8.5%. The market for neurovascular devices is anticipated to reach US$ 2.7 billion in 2022. Increasing demand for interventional neurology as a result of an increase in neurological illnesses is expected to lead to a US$6.2 billion increase in the market for neurovascular devices by 2032.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1323

With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Neurovascular Devices / Interventional Neurology Market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Neurovascular Devices / Interventional Neurology Market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Neurovascular Devices / Interventional Neurology Market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Neurovascular Devices / Interventional Neurology Market. With our extensive research and information about the past, current and future market scenario, the Neurovascular Devices / Interventional Neurology Market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1323

Critical Questions Answered in the Report

1. What are ongoing trends that will shape market growth curve for global Neurovascular Devices / Interventional Neurology Market?
2. What are the drivers and challenges affecting the Neurovascular Devices / Interventional Neurology Market demand?
3. What are the recent technological advancement in the Neurovascular Devices / Interventional Neurology Market?
4. What are key trends and opportunities that will prevail the revenue growth of Neurovascular Devices / Interventional Neurology Market players?
5. How will evolving regulatory policies impact the market growth?
6. What is the impact of Covid-19 on the Neurovascular Devices / Interventional Neurology Market?

Neurovascular Devices / Interventional Neurology Market: Segmentation

By Region

• North America
• Asia Pacific
• Europe
• Middle East & Africa
• Latin America

Detailed analysis on the geographical region and country wise insights are offered in the latest Neurovascular Devices / Interventional Neurology Market report with established market players as well as incumbents in the region.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1323

By Segment :

By Product:

• Aneurysm Coiling & Embolization Devices
• Cerebral Balloon Angioplasty
• Stentiny Systems
• Support Devices
• Neurothrombectomy Devices

By Disease Pathology:

• Ischemic Strokes
• Cerebral Aneuryms
• Cartotid Artery Stenosis
• Arteriovenous Malformations
• Fistulas
• Others

By End-User:

• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories
• Academic Institutes

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Market Players

Johnson & Johnson, Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra, and others

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Neurovascular Devices / Interventional Neurology Market

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/1323

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of  prominent players and emerging players in the Neurovascular Devices / Interventional Neurology Market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
• Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Top Related Reports Healthcare Market Insights:

Cell Line Development Services Market

Cervical Dysplasia Treatment Market

Bacterial Diagnostics in Aquaculture Market

Intravascular Imaging Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

 

According to Future Market Analysis, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in upcoming decades, surpassing US$ 601.614 Billion by the end of 2031.

As per FMI studies, the leading players in the antibodies market include F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company. These key players together account for 3 out of 4 sales of antibodies across the globe.

According to the reports of the National Stem Foundation (NSCF), about 4% of the global population is affected by some sort of autoimmune disease. The most common autoimmune diseases are diabetes, multiple sclerosis, Crohn’s disease, and rheumatoid arthritis. Due to these chronic diseases, the demand for antibodies market is estimated through the roof.

Key Insights

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson’s and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1330

Key Segments Covered in Antibodies Market Study

By Disease Indication

• Cardiovascular diseases
• CNS disorders
• Cancer
• Autoimmune Disorders

By Product Type

• Monoclonal antibodies
• Polyclonal antibodies
• Antibody-drug complexes (ADCs)

By End User

• Hospitals
• Long-term Care Facilities
• Research institutes

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1330

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global digital breast tomosynthesis equipment market Size is expected to reach 1,007.6 Mn in 2016, witnessing a year-over-year growth of 13.7%. Digital breast tomosynthesis (DBT) or 3-D mammography new installations (includes new equipment and 3-D upgradation) expected to reach 4,547 units in 2016, up from 4,061 units in 2015. In terms of revenue.

The global digital breast tomosynthesis equipment market was valued at US$ 886.6 Mn in 2015, and is projected to expand at a CAGR of 13.9% over forecast period 2016–2026. Increasing adoption of 3D mammography due to superior features over 2D mammography and favourable regulatory backing are factors fuelling market growth across the globe. The digital breast tomosynthesis equipment market would be driven by both new equipment purchases and upgradation of existing digital mammography machines.

Limitations concerning the flat nature of images achieved through a 2-D full-field digital mammography (FFDM) is influencing end-users to adopt DBT equipment for diagnosis of breast cancers. Digital breast tomosynthesis enables radiologists to analyse abnormalities lucidly, helping improve detection rates while reducing callbacks. In the backdrop of these factors, demand for digital breast tomosynthesis equipment is witnessing an uptick, and the trend is expected to gain further momentum in the future.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1241

Sales of DBTs have remained quite robust in the US in the recent past, making North America the most lucrative market globally. The market in the region is largely dominated by Hologic, Inc. although GE and Siemens Healthineers have also registered their presence by launching innovative DBT products at competitive prices. Total DBT equipment revenues in North America were pegged at 472.8 Mn in 2015, with the U.S. accounting for bulk of revenue share. New equipment installation base in North America is expected to reach 2,327 in 2016, up from 2,066 in 2015.

In addition to North America, digital breast tomosynthesis sales are also growing steadily in Western Europe and APEJ. Revenues in Western Europe are anticipated to grow by 13.4% in 2016, whereas APEJ is expected to increase at 12.2%.

By end-users, hospitals account for higher demand for DBTs vis-à-vis diagnostic centres. Many hospitals are in the process of upgrading their existing mammography machines, owing to which demand for DBT equipment is growing at a steady rate. However, high costs, coupled with lack of awareness can impede adoption rates in both hospitals and diagnostic centres, and slow down the growth of the market globally. Installations of DBTs in hospitals totalled 3,020 in 2015, representing a market value worth 542.8 Mn.

Key players in the global digital breast tomosynthesis equipment market include Hologic Inc., GE Healthcare, Siemens Healthineers, Internazionale Medico Scientifica, Fujifilm, and Planmed Oy. The top 3 players – Hologic, Inc., GE Healthcare, and Siemens Healthineers collectively account for nearly 90% revenue share of the market.

Get In Touch With Our Team For 20% Flat Discount :

https://www.futuremarketinsights.com/ask-question/rep-gb-1241

Long-term Outlook: In terms of revenues, the global tomosynthesis equipment market is expected to increase at 13.9% CAGR during the forecast period 2016-2026. Total installations of DBT equipment are anticipated to reach 17,700 units.

Key Segments Covered

By Product type

• DBT Equipment

• 3-D Upgradation

By End User

• Hospital

• Diagnostic centres

Key Regions Covered

• North America

• Latin America

• Western Europe

• Eastern Europe

• APEJ

• Japan

• MEA

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1241

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global silent scan technology market size volume, by the hospital segment is forecasted to grow at a CAGR of close to 5% for a period of 2016 through 2026. The Silent scan technology has been in the news lately, owing to its steady adoption among end-users looking for noise-free MRI scanning procedures. As per Future Market Insight’s analysis, Silent Scan Technology has an installation base in the range of 1% to 3% of the total global MRI machines. The company forecasts the market to grow at an attractive CAGR during the 10 year forecast period of 2016 through 202

Adoption of silent scan technology continues to face major challenges, with high cost and a general lack of awareness being the key restraints, according to a new survey by Future Market Insights (FMI). The survey was conducted among respondents from 300 global healthcare facilities, spanning sectors in North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa (MEA), Asia Pacific excluding Japan (APEJ), and Japan. Majority of the respondents in the survey were from the U.S., Canada, Germany, the U.K., the Netherlands, Belgium, Australia, Saudi Arabia and the U.A.E.

FMI’s survey found that adoption varied widely based on the type of healthcare setting. While hospitals are the leading end-users, respondents in private hospitals are more receptive towards the adoption of silent scan technology. Satisfaction with the overall effectiveness of silent scan MRIs is exceedingly high and there’s a sense of understanding that silent scan MRIs do what they promise—quiet, noise-free MRI scans. “Silent scan MRIs received a higher rating than their noisy counterparts from respondents, and this represents an underlying sentiment that the technology per se isn’t the root cause for slow adoption,” added Vrishali.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1623

According to FMI’s market forecast report, silent scan installation base is anticipated to reach 1,815 units in 2016, up from 1,015 units in 2015. Silent scanners constituted 1% of total MRI machine installations in 2015, and owing to their positive reception among end-users, their adoption is expected to witness a steady increase during the forecast period.

Hospitals are the leading end-use segment in the global silent scan technology market, and are expected to account for nearly 50% volume share of the market in 2016. Regionally, North America and Asia Pacific excluding Japan (APEJ) are the two largest markets, accounting for over 50% share of the global market in terms of volume. The market in these two regions is dominated by the U.S. and China respectively.

FMI’s report forecasts the global silent scan technology market to increase at a steady compound annual growth rate (CAGR) of 5.4% through 2026.

Although 44% of responding healthcare facilities currently own an MRI machine with silent- or soft-scan technology, a majority of them were averse to installing one in the future. In addition to high cost of silent scan MRIs and lack of awareness, respondents cited absence of distribution facility and insufficiency of technology as other key factors for not having an MRI machine with silent scan technology.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1623

Key Regions/Countries Covered

End User:

• Hospitals
  • Public Hospitals
  • Private Hospitals
• Diagnostic Imaging Centres
• Ambulatory Surgical Centres

Key Regions/Countries Covered:

• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Rest of Latin America
• Western Europe
  • U.K.
  • France
  • Germany
  • Spain
  • Italy
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Rest of Eastern Europe
• Asia Pacific Excluding Japan (APEJ)
  • China
  • India
  • Australia & New Zealand
  • Rest Of APEJ
• Japan
• Middle East & Africa
  • GCC countries
  • South Africa
  • Rest of MEA

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1623

Read Related Reports:

Pancreatic Stone Protein Testing Market Value : The pancreatic stone protein testing market is likely to record a strong CAGR of 1.8% during the forecast period. The pancreatic stone protein testing market is currently valued at US$ 3 Bn in 2022 and is likely to reach US$ 3.59 Bn by 2032.

Multiple Unit Pellet Systems Market Sales : The global multiple unit pellet systems (MUPS) market was valued at US$ 3.48 Bn in the year 2021, expanding at a CAGR of 3.5% to reach an ~US$ 5.07 Bn by the end of 2032.

Humeral Implants Market Volume : The global humeral implants market is likely to be valued at US$ 963.8 Million in 2022. From 2022 to 2032, sales of humeral implants are expected to flourish at a 7.1% CAGR, reaching US$ 2,106 Million.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global wearable medical devices market size is expected to reach a market valuation of US$ 27.29 Billion by 2022, accelerating with a moderate CAGR of 28.1% by 2022-2032. The wearable medical devices market is anticipated to be valued at about US$ 324.65 Billion by 2032.

A patient’s most likely diagnosis and treatments can be identified using 5G and AI. AI can also help healthcare providers predict which patients are anticipated to have complications after surgery to perform preventative actions. Learning in real-time with large amounts of data typically necessitates networks with high availability and high throughput.

With the advent of 5G networks, healthcare providers can use AI applications to provide immediate, high-quality care to patients worldwide. Therefore, cutting-edge advancements such as artificial intelligence and fifth-generation wireless networks are expected to impact wearable medical devices significantly.

The wearable medical devices market is expanding. Individuals that typically purchase such items are those who are open to new experiences and ideas. The increasing number of early adopters and innovators in both developed and developing nations is anticipated to boost sales of wearable medical devices. The increasing demand for novel health monitoring techniques among athletes and fitness buffs is anticipated to propel the worldwide wearable medical devices market. An appreciable fraction of persons in the US and Canada are early adopters. So, the demand for wearable medical devices in North America is anticipated to expand at a higher rate.

Therapeutics, monitoring and diagnostics, foetal and obstetric monitoring, cardiovascular monitoring, and glucose monitoring are just a few of the many uses for wearable medical devices. In this category, therapeutic medical gadgets patients can wear are expected to dominate.

The FMI analysis predicts that by 2025, the market share of therapeutic medical devices that can be worn would exceed 50%. Among the many lifestyle-related conditions, lung problems, diabetes, and hearing loss contribute to this. During the evaluation phase, we don’t expect this tendency to reverse.

Improvements in both design and technology have boosted sales of wearable medical devices in recent years. However, adoption rates in the business continue to be challenged by several variables. The initial investment and ongoing upkeep of wearable technology might be costly for many people. Among other components, failure in sensors, batteries, and chips often necessitates frequent maintenance and repair, which slows consumer acceptance.

Additionally, several nations do not supply enough medical wearable reimbursement options for their citizens. Because of this, sales of wearable medical devices are expected to stagnate in developed and developing nations.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-826

Key Takeaways

• The wearable medical devices market is anticipated to reach a valuation of US$ 324.65 Billion by 2032.
• North America contributed for 38.1% of global revenue in 2020 because to rising rates of cardiovascular disease, diabetes, and cancer.
• Market growth is anticipated as a result of the increased use of wearable devices for health management during COVID-19.
• Rising prevalence of target diseases due to an ageing population and the need to minimise healthcare spending are driving the wearable medical device market.

Competitive Landscape

Although the wearable medical devices market is somewhat concentrated, a handful of industry giants control most sales. These businesses invest heavily in research and development of new items, followed by careful timing in releasing such products to the market.

Companies that now dominate the wearable medical devices market are focusing on diversifying their growth strategies, such as forging strategic partnerships, merging with other businesses, and expanding their product lines.

Recent Developments

• In April 2021, Alvalux Medical, a Belgian MedTech wearables manufacturer, announced that it had been granted a second patent by the United States Patent and Trademark Office for its new ocular insert device, which is intended to allow patients to treat retinal disorders at home through photo-biomodulation (PBM) therapy.
• As an additional comfort measure, 3M has announced the creation of a novel silicone adhesive material with conformable and breathable properties that is expected to be used in wearable medical devices with the goal of reducing the amount of skin that must be removed.
• In March of 2021, EOFlow, a provider of wearable drug delivery solutions, announced the release of a new smartphone application designed to be used in tandem with wearable insulin delivery devices.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-826

Wearable Medical Devices Market By Segmentation

By Product:

• Wearable Monitoring and Diagnostic Devices
• Fetal and Obstetric Devices
  • Wearable Fetal Monitors
  • Infant Motion Sensing Monitors
• Continuous Glucose Monitoring Devices
• Cardiac Monitoring Devices
  • Wearable Heart Rate Monitors
  • Wearable Pulse Oximeters
  • Wearable Blood Pressure Monitors
• Wearable Therapeutic Medical Device
• Hearing Aid
• Insulin Pump
• Respiratory Therapy Devices
  • Sleep Apnea Devices
  • Non-invasive Ventilation
• Health and Fitness Devices

By Application:

• Patient Monitoring
• Home Healthcare
• Health and Fitness

By Distribution Channel:

• Hospital Pharmacies
• Clinics
• Online Channels
• Hypermarkets

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-826

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs